Cover Image

Xpert MTB/RIF for tuberculosis testing: access and price in highly privatised health markets

Saved in:

Bibliographic Details
Main Authors:	Lekha Puri (Author), Collins Oghor (Author), Claudia M Denkinger (Author), Madhukar Pai (Author)
Format:	Book
Published:	Elsevier, 2016-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF
by: Nirros Ponnudurai, et al.
Published: (2018)

Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020)

Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF
by: Dr. Gavin J Churchyard, PhD, et al.
Published: (2015)

Xpert MTB/RIF Ultra for Tuberculosis Testing in Children: A Mini-Review and Commentary
by: Rachel R. Atherton, et al.
Published: (2019)

Validation and implementation of GeneXpert MTB/RIF for diagnosis of Tuberculosis in Ecuador
by: José Marcelo Ortíz-Jimenes, et al.
Published: (2019)

Performance of Xpert® MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi
by: Tarsizio Chikaonda, et al.
Published: (2017)

Diagnostic accuracy of Xpert MTB/RIF and Xpert ultra tests in pulmonary and extrapulmonary tuberculosis compared to Löwenstein-Jensen culture
by: Miguel Hueda-Zavaleta, et al.
Published: (2024)

Development of dried tube specimens for Xpert MTB/RIF proficiency testing
by: Kyle DeGruy, et al.
Published: (2020)

Xpert MTB/RIF: a game changer for the diagnosis of pulmonary tuberculosis in children?
by: Annelies Van Rie
Published: (2013)

Utilization of GeneXpert MTB/RIF in the Southern Department of Haiti
by: T. Kedia, et al.
Published: (2015)

Diagnosis of cutaneous tuberculosis (lymph node scrofuloderma) using the Xpert MTB/RIF® method,
by: Lilian Lemos Costa, et al.
Published: (2021)

Evaluation of the GeneXpert MTB/RIF to diagnose tuberculosis in a public health laboratory
by: Mohanna Damasceno Arbués, et al.
Published: (2024)

Retrospective observational study to compare Xpert MTB/RIF assay with other diagnostic tests in lymph node tuberculosis
by: Nithya Haridas, et al.
Published: (2022)

Investigation of OMNIgene·SPUTUM performance in delayed tuberculosis testing by smear, culture, and Xpert MTB/RIF assays in Uganda
by: C.D. Kelly-Cirino, et al.
Published: (2019)

Impact of the GeneXpert® MTB/RIF rapid molecular test on tuberculosis detection: temporal trends and vulnerable territories
by: Thaís Zamboni Berra, et al.

Utility of Xpert MTB/RIF Assay for Diagnosis of Pediatric Tuberculosis Under Programmatic Conditions in India
by: Rakesh Yadav, et al.
Published: (2020)

Xpert® MTB/RIF assay on formalin-fixed paraffin-embedded tissues in the diagnosis of extrapulmonary tuberculosis
by: Allan N. Njau, et al.
Published: (2019)

Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa
by: Keertan Dheda, et al.
Published: (2014)

Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa
by: Ivor Langley, et al.
Published: (2015)

Pooling sputum for Xpert MTB/RIF and Xpert Ultra testing during the Covid-19 pandemic in Lao People's Democratic Republic.
by: Vibol Iem, et al.
Published: (2022)

Pooling sputum for Xpert MTB/RIF and Xpert Ultra testing during the Covid-19 pandemic in Lao People's Democratic Republic
by: Vibol Iem, et al.
Published: (2022)

A Model of Tuberculosis Screening for Pregnant Women in Resource-Limited Settings Using Xpert MTB/RIF
by: Eleanor R. Turnbull, et al.
Published: (2012)

Evaluation of Xpert MTB/RIF Ultra for the Diagnosis of Extrapulmonary Tuberculosis: A Retrospective Analysis in Saudi Arabia
by: Mousa J. Slail, et al.
Published: (2023)

Rolling out Xpert MTB/RIF® for tuberculosis detection in HIV-positive populations: An opportunity for systems strengthening
by: Ishani Pathmanathan, et al.
Published: (2017)

Operational lessons drawn from pilot implementation of Xpert MTB/Rif in Brazil
by: Betina Durovni, et al.
Published: (2014)

Effectiveness of Xpert MTB/RIF and the Line Probe Assay tests for the rapid detection of drug-resistant tuberculosis in the Central African Republic.
by: Alain Farra, et al.
Published: (2023)

Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality
by: Elise De Vos, et al.
Published: (2023)

Validación e implementación de GeneXpert MTB/RIF para diagnóstico de tuberculosis en Ecuador
by: Ortiz-Jiménez, José Marcelo, et al.
Published: (2019)

A global proficiency testing programme for Xpert® MTB/RIF using dried tube specimens, 2013-2015
by: Katherine Klein, et al.
Published: (2020)

Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa
by: Naseem Cassim, et al.
Published: (2021)

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
by: Talemwa Nalugwa, et al.
Published: (2020)

Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach
by: Ivor Langley, MSc, et al.
Published: (2014)

Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa
by: Denise Evans, et al.
Published: (2018)

Impact of Xpert MTB/RIF on Outcomes of Adults Hospitalized With Spinal Tuberculosis: Findings From a Comparative Cohort in Beijing, China
by: Jun Fan, et al.
Published: (2022)

Utilization of GeneXpert MTB/RIF Assay for Prevalence Mapping of Rifampicin Resistant Mycobacterium tuberculosis in A Teaching Hospital, Indonesia
by: P. Christopher, et al.
Published: (2020)

A comparative study of ultrasound-guided puncture biopsy combined with histopathology and Xpert MTB/RIF in the diagnosis of lymph node tuberculosis
by: Xiangyu Meng, et al.
Published: (2023)

Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation
by: Prof Anna Vassall, PhD, et al.
Published: (2017)

Performance of Xpert/MTB/RIF assay for childhood pulmonary tuberculosis among HIV negative children with real world evidence in China
by: Lu Xia, et al.
Published: (2020)

Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda
by: Stella Zawedde-Muyanja, et al.
Published: (2020)

Comparing the cost-effectiveness of the MPT64-antigen detection test to Xpert MTB/RIF and ZN-microscopy for the diagnosis of Extrapulmonary Tuberculosis: An economic evaluation modelling study.
by: Shoaib Hassan, et al.
Published: (2024)